AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2017
Nov 6, 2017
31949_dirs_2017-11-06_103afbb0-9c38-43ee-b19c-95a7ed1359f0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2017-11-02
Reporting Person: Kirson Eilon D. (Chief Science Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-02 | Ordinary Shares | S | 300 | $22.00 | Disposed | 40701 | Direct |
| 2017-11-03 | Ordinary Shares | S | 3100 | $22.00 | Disposed | 37601 | Direct |
Footnotes
F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3